bosentan anhydrous has been researched along with Hand Dermatosis in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (36.36) | 29.6817 |
2010's | 7 (63.64) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abuowda, Y; Almeida, RS; Matos-Costa, J; Oliveira, AA; Pego, P; Santos, C | 1 |
Belz, D; Hunzelmann, N; Moinzadeh, P | 1 |
Matucci-Cerinic, M; Seibold, JR | 1 |
Ambach, A; Bonnekoh, B; Gollnick, H; Seo, W | 1 |
Denton, CP; Matucci-Cerinic, M; Pope, JE; Steen, V | 1 |
Black, CM; Carpentier, P; Denton, CP; Doyle, MK; Fessler, BJ; Furst, DE; Hellmich, B; Hsu, VM; Korn, JH; Kramer, F; Matucci-Cerinic, M; Mayes, MD; Medsger, TA; Merkel, PA; Morganti, A; Pope, JE; Seibold, JR; Sweiss, NJ; Wigley, FM | 1 |
Weinerth, J; Wiesent, F | 1 |
Pope, J; Zelenietz, C | 1 |
Kurgyis, Z; Lang, MU; Ruzicka, T; Sárdy, M; Sick, I; Varga, R | 1 |
Hasegawa, M; Hattori, T; Ishikawa, O; Nagai, Y; Okada, E; Tago, O | 1 |
Varga, J | 1 |
3 review(s) available for bosentan anhydrous and Hand Dermatosis
Article | Year |
---|---|
Digital ulcers and outcomes assessment in scleroderma.
Topics: Bosentan; Fingers; Hand Dermatoses; Humans; Iloprost; Ischemia; Scleroderma, Systemic; Severity of Illness Index; Skin Ulcer; Sulfonamides; Treatment Outcome; Vasodilator Agents | 2008 |
Digital ulcers: overt vascular disease in systemic sclerosis.
Topics: Antihypertensive Agents; Bosentan; Databases, Factual; Endothelium, Vascular; Fingers; Hand Dermatoses; Humans; Raynaud Disease; Scleroderma, Systemic; Skin Ulcer; Sulfonamides | 2009 |
Differences in disability as measured by the Health Assessment Questionnaire between patients with and without digital ulcers in systemic sclerosis: a post hoc analysis of pooled data from two randomised controlled trials in digital ulcers using bosentan.
Topics: Antihypertensive Agents; Bosentan; Disability Evaluation; Fingers; Hand Dermatoses; Humans; Randomized Controlled Trials as Topic; Scleroderma, Systemic; Skin Ulcer; Sulfonamides | 2010 |
2 trial(s) available for bosentan anhydrous and Hand Dermatosis
Article | Year |
---|---|
Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial.
Topics: Adult; Bosentan; Double-Blind Method; Drug Administration Schedule; Endothelin Receptor Antagonists; Female; Fingers; Hand Dermatoses; Humans; Male; Middle Aged; Scleroderma, Systemic; Skin Ulcer; Sulfonamides; Treatment Outcome; Wound Healing | 2011 |
New hope for systemic sclerosis patients with digital ulcers.
Topics: Administration, Oral; Bosentan; Chemical and Drug Induced Liver Injury; Double-Blind Method; Endothelin Receptor Antagonists; Fingers; Foot Dermatoses; Hand Dermatoses; Humans; Scleroderma, Localized; Scleroderma, Systemic; Skin Ulcer; Sulfonamides; Toes; Treatment Outcome | 2005 |
6 other study(ies) available for bosentan anhydrous and Hand Dermatosis
Article | Year |
---|---|
Treatment of digital ulcers in systemic sclerosis: Case series study of thirteen patients and discussion on outcome.
Topics: Aged; Aged, 80 and over; Alprostadil; Bosentan; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Female; Fingers; Hand Dermatoses; Humans; Male; Middle Aged; Reproducibility of Results; Scleroderma, Systemic; Skin Ulcer; Sulfonamides; Time Factors; Treatment Outcome; Vasodilator Agents; Wound Healing | 2017 |
[Digital ulcers in systemic scleroderma].
Topics: Bosentan; Fingers; Hand Dermatoses; Humans; Iloprost; Phosphodiesterase 5 Inhibitors; Scleroderma, Systemic; Skin Ulcer; Sulfonamides; Wound Healing | 2014 |
Low-dose combination therapy of severe digital ulcers in diffuse progressive systemic sclerosis with the endothelin-1 receptor antagonist bosentan and the phosphodiesterase V inhibitor sildenafil.
Topics: Aged; Bosentan; Drug Therapy, Combination; Endothelin Receptor Antagonists; Female; Fingers; Hand Dermatoses; Humans; Phosphodiesterase Inhibitors; Piperazines; Purines; Scleroderma, Diffuse; Sildenafil Citrate; Sulfonamides; Sulfones; Treatment Outcome; Ulcer | 2009 |
[Digital ulcers in systemic sclerosis--an interdisciplinary challenge].
Topics: Angiography; Antihypertensive Agents; Arm; Bosentan; Cooperative Behavior; CREST Syndrome; Endothelin Receptor Antagonists; Fatal Outcome; Fingers; Follow-Up Studies; Hand Dermatoses; Humans; Iloprost; Interdisciplinary Communication; Leg; Male; Middle Aged; Scleroderma, Limited; Skin Ulcer; Sulfonamides; Vasodilator Agents | 2010 |
Bosentan is effective against digital ulcerations and hyperkeratosis in systemic sclerosis.
Topics: Antihypertensive Agents; Bosentan; Female; Hand Dermatoses; Humans; Keratosis; Middle Aged; Raynaud Disease; Scleroderma, Systemic; Skin Ulcer; Sulfonamides | 2011 |
Bosentan for digital ulcers in patients with systemic sclerosis.
Topics: Adult; Aged; Antihypertensive Agents; Bosentan; Chemical and Drug Induced Liver Injury; Female; Hand Dermatoses; Humans; Male; Middle Aged; Scleroderma, Systemic; Skin Ulcer; Sulfonamides; Treatment Outcome; Young Adult | 2012 |